2025-2031 Global Biosimulation Industry Research & Trends Analysis Report- YH Research

Home > Reports >Medical Devices & Consumables > 2025-2031 Global Biosimulation Industry Research & Trends Analysis Report

2025-2031 Global Biosimulation Industry Research & Trends Analysis Report

Publication Date: 2025-11-07
Report Id: 2704131
Industry: Medical Devices & Consumables
Report Page: 117
Chart: 120

PDF Download

Publication Date: 2025-11-07
Report Id: 2704131
Industry: Medical Devices & Consumables
Report Page: 117
Chart: 120

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Product Overview and Scope of Biosimulation
1.2 Global Biosimulation Market Size and Forecast
1.3 China Biosimulation Market Size and Forecast
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Biosimulation Share in Global Market, 2020-2031
1.4.2 Biosimulation Market Size: China VS Global, 2020-2031
1.5 Biosimulation Market Dynamics
1.5.1 Biosimulation Market Drivers
1.5.2 Biosimulation Market Restraints
1.5.3 Biosimulation Industry Trends
1.5.4 Biosimulation Industry Policy

2 Competitive Landscape by Company
2.1 Global Biosimulation Revenue by Company, 2020-2025
2.2 Global Biosimulation Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Biosimulation Concentration Ratio
2.4 Global Biosimulation Mergers & Acquisitions, Expansion Plans
2.5 Global Biosimulation Manufacturers Product Type
2.6 Global Geographic Distribution of Biosimulation Companies

3 China Competitive Situation by Company
3.1 China Biosimulation Revenue by Company, 2020-2025
3.2 China Biosimulation Biosimulation Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.3 China Biosimulation Market, Revenue Percentage of Local Players VS Foreign Players (2020-2031)

4 Industry Chain Analysis
4.1 Biosimulation Industry Chain
4.2 Biosimulation Upstream Analysis
4.3 Biosimulation Midstream Analysis
4.4 Biosimulation Downstream Analysis

5 Sights by Type
5.1 Biosimulation Classification
5.1.1 Molecular Simulation
5.1.2 Clinical Trials
5.1.3 Toxicity Prediction Software
5.1.4 Other
5.2 by Type, Global Biosimulation Market Size & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Biosimulation Market Size, 2020-2031

6 Sights by Application
6.1 Biosimulation Segment by Application
6.1.1 Hospital
6.1.2 Scientific Research Institutions
6.1.3 Government Department
6.1.4 Other
6.2 by Application, Global Biosimulation Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Application, Global Biosimulation Market Size, 2020-2031

7 Sights by Region
7.1 By Region, Global Biosimulation Market Size, 2020 VS 2024 VS 2031
7.2 By Region, Global Biosimulation Market Size, 2020-2031
7.3 North America
7.3.1 North America Biosimulation Market Size & Forecasts, 2020-2031
7.3.2 By Country, North America Biosimulation Market Size Market Share
7.4 Europe
7.4.1 Europe Biosimulation Market Size & Forecasts, 2020-2031
7.4.2 By Country, Europe Biosimulation Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Biosimulation Market Size & Forecasts, 2020-2031
7.5.2 By Country/Region, Asia Pacific Biosimulation Market Size Market Share
7.6 South America
7.6.1 South America Biosimulation Market Size & Forecasts, 2020-2031
7.6.2 By Country, South America Biosimulation Market Size Market Share
7.7 Middle East & Africa

8 Sights by Country Level
8.1 By Country, Global Biosimulation Market Size & CAGR，2020 VS 2024 VS 2031
8.2 By Country, Global Biosimulation Market Size, 2020-2031
8.3 United States
8.3.1 United States Biosimulation Market Size, 2020-2031
8.3.2 By Company, United States Biosimulation Revenue Market Share, 2024
8.3.3 by Type, United States Biosimulation Revenue Market Share, 2024 VS 2031
8.3.4 by Application, United States Biosimulation Revenue Market Share, 2024 VS 2031
8.4 Europe
8.4.1 Europe Biosimulation Market Size, 2020-2031
8.4.2 By Company, Europe Biosimulation Revenue Market Share, 2024
8.4.3 by Type, Europe Biosimulation Revenue Market Share, 2024 VS 2031
8.4.4 by Application, Europe Biosimulation Revenue Market Share, 2024 VS 2031
8.5 China
8.5.1 China Biosimulation Market Size, 2020-2031
8.5.2 By Company, China Biosimulation Revenue Market Share, 2024
8.5.3 by Type, China Biosimulation Revenue Market Share, 2024 VS 2031
8.5.4 by Application, China Biosimulation Revenue Market Share, 2024 VS 2031
8.6 Japan
8.6.1 Japan Biosimulation Market Size, 2020-2031
8.6.2 By Company, Japan Biosimulation Revenue Market Share, 2024
8.6.3 by Type, Japan Biosimulation Revenue Market Share, 2024 VS 2031
8.6.4 by Application, Japan Biosimulation Revenue Market Share, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Biosimulation Market Size, 2020-2031
8.7.2 By Company, South Korea Biosimulation Revenue Market Share, 2024
8.7.3 by Type, South Korea Biosimulation Revenue Market Share, 2024 VS 2031
8.7.4 by Application, South Korea Biosimulation Revenue Market Share, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Biosimulation Market Size, 2020-2031
8.8.2 By Company, Southeast Asia Biosimulation Revenue Market Share, 2024
8.8.3 by Type, Southeast Asia Biosimulation Revenue Market Share, 2024 VS 2031
8.8.4 by Application, Southeast Asia Biosimulation Revenue Market Share, 2024 VS 2031
8.9 India
8.9.1 India Biosimulation Market Size, 2020-2031
8.9.2 By Company, India Biosimulation Revenue Market Share, 2024
8.9.3 by Type, India Biosimulation Revenue Market Share, 2024 VS 2031
8.9.4 by Application, India Biosimulation Revenue Market Share, 2024 VS 2031
8.10 Middle East & Africa
8.10.1 Middle East & Africa Biosimulation Market Size, 2020-2031
8.10.2 By Company, Middle East & Africa Biosimulation Revenue Market Share, 2024
8.10.3 by Type, Middle East & Africa Biosimulation Revenue Market Share, 2024 VS 2031
8.10.4 by Application, Middle East & Africa Biosimulation Revenue Market Share, 2024 VS 2031

9 Company Profile
9.1 Accelrys
9.1.1 Accelrys Company Information, Head Office, Market Area, and Industry Position
9.1.2 Accelrys Company Profile and Main Business
9.1.3 Accelrys Biosimulation Models, Specifications, and Application
9.1.4 Accelrys Biosimulation Revenue and Gross Margin, 2020-2025
9.1.5 Accelrys Recent Developments
9.2 Certara
9.2.1 Certara Company Information, Head Office, Market Area, and Industry Position
9.2.2 Certara Company Profile and Main Business
9.2.3 Certara Biosimulation Models, Specifications, and Application
9.2.4 Certara Biosimulation Revenue and Gross Margin, 2020-2025
9.2.5 Certara Recent Developments
9.3 Simulation Plus
9.3.1 Simulation Plus Company Information, Head Office, Market Area, and Industry Position
9.3.2 Simulation Plus Company Profile and Main Business
9.3.3 Simulation Plus Biosimulation Models, Specifications, and Application
9.3.4 Simulation Plus Biosimulation Revenue and Gross Margin, 2020-2025
9.3.5 Simulation Plus Recent Developments
9.4 Dassault Systems SA
9.4.1 Dassault Systems SA Company Information, Head Office, Market Area, and Industry Position
9.4.2 Dassault Systems SA Company Profile and Main Business
9.4.3 Dassault Systems SA Biosimulation Models, Specifications, and Application
9.4.4 Dassault Systems SA Biosimulation Revenue and Gross Margin, 2020-2025
9.4.5 Dassault Systems SA Recent Developments
9.5 Schrodinger
9.5.1 Schrodinger Company Information, Head Office, Market Area, and Industry Position
9.5.2 Schrodinger Company Profile and Main Business
9.5.3 Schrodinger Biosimulation Models, Specifications, and Application
9.5.4 Schrodinger Biosimulation Revenue and Gross Margin, 2020-2025
9.5.5 Schrodinger Recent Developments
9.6 Advanced Chemistry Development
9.6.1 Advanced Chemistry Development Company Information, Head Office, Market Area, and Industry Position
9.6.2 Advanced Chemistry Development Company Profile and Main Business
9.6.3 Advanced Chemistry Development Biosimulation Models, Specifications, and Application
9.6.4 Advanced Chemistry Development Biosimulation Revenue and Gross Margin, 2020-2025
9.6.5 Advanced Chemistry Development Recent Developments
9.7 Chemical Computing Group
9.7.1 Chemical Computing Group Company Information, Head Office, Market Area, and Industry Position
9.7.2 Chemical Computing Group Company Profile and Main Business
9.7.3 Chemical Computing Group Biosimulation Models, Specifications, and Application
9.7.4 Chemical Computing Group Biosimulation Revenue and Gross Margin, 2020-2025
9.7.5 Chemical Computing Group Recent Developments
9.8 Entelos Holding Corporation
9.8.1 Entelos Holding Corporation Company Information, Head Office, Market Area, and Industry Position
9.8.2 Entelos Holding Corporation Company Profile and Main Business
9.8.3 Entelos Holding Corporation Biosimulation Models, Specifications, and Application
9.8.4 Entelos Holding Corporation Biosimulation Revenue and Gross Margin, 2020-2025
9.8.5 Entelos Holding Corporation Recent Developments
9.9 Genedata AG
9.9.1 Genedata AG Company Information, Head Office, Market Area, and Industry Position
9.9.2 Genedata AG Company Profile and Main Business
9.9.3 Genedata AG Biosimulation Models, Specifications, and Application
9.9.4 Genedata AG Biosimulation Revenue and Gross Margin, 2020-2025
9.9.5 Genedata AG Recent Developments
9.10 Physiomics PLC
9.10.1 Physiomics PLC Company Information, Head Office, Market Area, and Industry Position
9.10.2 Physiomics PLC Company Profile and Main Business
9.10.3 Physiomics PLC Biosimulation Models, Specifications, and Application
9.10.4 Physiomics PLC Biosimulation Revenue and Gross Margin, 2020-2025
9.10.5 Physiomics PLC Recent Developments

10 Conclusion

11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer

According to YH Research, the global market for Biosimulation should grow from US$ 2130 million in 2024 to US$ 4670 million by 2031, with a CAGR of 11.9% for the period of 2025-2031.

China Biosimulation market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031.

Biosimulation

According to YH Research, the global market for Biosimulation should grow from US$ 2130 million in 2024 to US$ 4670 million by 2031, with a CAGR of 11.9% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

The United States Biosimulation market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031.

In terms of product type, Molecular Simulation segment holds a share about % in 2024, and will reach % in 2031; while in terms of end use, Hospital has a share approximately % in 2024, and will grow at a CAGR % during 2025 and 2031.

The global key manufacturers of Biosimulation include Accelrys, Certara, Simulation Plus, Dassault Systems SA, Schrodinger, Advanced Chemistry Development, Chemical Computing Group, Entelos Holding Corporation, Genedata AG, Physiomics PLC, etc. In 2024, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Biosimulation. Report Highlights:
(1) Global Biosimulation market size (value), history data from 2020-2024, and forecast data from 2025 to 2031.

(2) Global Biosimulation market competitive situation, revenue, and market share, from 2020 to 2024.

(3) China Biosimulation market competitive situation, revenue, and market share, from 2020 to 2024.

(4) Global Biosimulation segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Biosimulation segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Biosimulation industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
    Molecular Simulation
    Clinical Trials
    Toxicity Prediction Software
    Other

Market segment by Application, can be divided into
    Hospital
    Scientific Research Institutions
    Government Department
    Other

Market segment by players, this report covers
    Accelrys
    Certara
    Simulation Plus
    Dassault Systems SA
    Schrodinger
    Advanced Chemistry Development
    Chemical Computing Group
    Entelos Holding Corporation
    Genedata AG
    Physiomics PLC